Invention Grant
- Patent Title: Extracellular matrix compositions for the treatment of cancer
- Patent Title (中): 用于治疗癌症的细胞外基质组合物
-
Application No.: US12363479Application Date: 2009-01-30
-
Publication No.: US08852637B2Publication Date: 2014-10-07
- Inventor: Gail K. Naughton , Emmett Pinney
- Applicant: Gail K. Naughton , Emmett Pinney
- Applicant Address: US CA San Diego
- Assignee: Histogen, Inc.
- Current Assignee: Histogen, Inc.
- Current Assignee Address: US CA San Diego
- Agency: DLA Piper LLP (US)
- Main IPC: C12N5/00
- IPC: C12N5/00 ; A61K35/12 ; A61K31/282 ; A61K9/14
Abstract:
The present invention is directed to methods of inhibiting cancer cell growth or proliferation by contacting the cancer cell with an extracellular matrix (ECM) composition. Also provided are methods of delivering a chemotherapeutic agent to a cancer cell by contacting a cancer cell with an extracellular matrix composition containing a chemotherapeutic agent. Also provided are compositions containing ECM and a chemotherapeutic agent.
Public/Granted literature
- US20100124573A1 EXTRACELLULAR MATRIX COMPOSITIONS FOR THE TREATMENT OF CANCER Public/Granted day:2010-05-20
Information query
